Increasing studies have confirmed that abnormally expressed microRNAs (miRNAs) take part in the carcinogenesis as well as the aggravation of hepatocellular carcinoma (HCC). However, little information is currently available about miR-1914 in HCC.
| INTRODUC TI ON
Hepatocellular carcinoma (HCC) remains one of the most common malignancies and is the main cause of cancer-related deaths worldwide. 1 Despite the remarkable advancement in therapeutic strategies, 2,3 the prognosis remains unsatisfactory because only 10%-37% of patients are suitable candidates for surgery because of late-stage tumours or hepatic functional failure. 4 Thus, further exploration of the mechanisms underlying HCC progression may help provide novel therapeutic targets.
As a set of evolutionarily conserved small non-coding RNAs, mi-croRNAs (miRNAs) have been identified as post-transcriptional gene expression regulators that act via combining with complementary sequences within 3′-untranslated regions (UTRs) of corresponding protein-coding genes, eventually leading to mRNA degradation or translation inhibition. 5, 6 Mounting studies have indicated that miRNAs are vital in diverse biological processes in HCC, including cell proliferation, cell cycle progression, apoptosis, differentiation and metastasis, because they can regulate tumour suppressors or oncogenes. 7, 8 Therefore, specific miRNAs are known to be potential therapeutic, diagnostic and prognostic biological markers in HCC. 9 miR-1914, a newly identified cancer-related microRNA, is aberrantly expressed and has become a predictor of cancer patients' survival. [10] [11] [12] miR-1914 facilitates cancer progression by repressing the expression of nuclear factor IX in colorectal cancer (CRC), and plasma miR-1914 suppresses chemoresistance in CRC patients. [13] [14] [15] Moreover, miR-1914 is dysregulated in stomach cancer. However, the expression status and specific biological effects of miR-1914, as well as the underlying molecular mechanism, require further exploration in HCC.
Herein, we revealed for the first time that the level of miR-1914 was decreased in HCC and correlated with adverse prognostic features, confirming its critical role in HCC progression and potential as a target for treating HCC. Normal immortalized human hepatocyte LO2 cells and HCC cell lines (Hep3B, HepG2, Huh7, MHCC-97L and HCCLM3) (Chinese Academy of Sciences, Shanghai, China) were cultured in DMEM (Invitrogen, Carlsbad, USA) with 10 μL 10% FBS (Gibco, Grand Island, USA) at 37°C and 5% CO 2 .
| MATERIAL S AND ME THODS

| Clinical samples and cell culture
| RNA extraction and qRT-PCR
qRT-PCR was performed as reported previously. 16, 17 Total RNA was extracted according to the protocol of TRIzol reagent (Invitrogen, Carlsbad, CA, USA). qPCR primers against miR-1914 (HmiRQP0270), U6 (HmiRQP9001), GPR39 (HQP008237) and GAPDH (HQP006940) were obtained from GeneCopoeia (Guangzhou, China).
| Immunohistochemical staining
Immunohistochemical staining (IHC) was conducted using an SABC kit (Maxim, Fuzhou, China) according to the manufacturer's instructions. In summary, HCC tissue sections were incubated with GPR39
(1:300, Abcam, USA) overnight at 4°C and then flushed with PBS and re-incubated with biotinylated secondary antibodies (Goldenbridge, Zhongshan, China) according to the SP-IHC assay instructions. The experiment was performed according to our previously reported protocol. 18 
| Western blot analysis
Proteins were separated by SDS-PAGE and transferred to PVDF membranes. The experiment was performed as previously described. 7
| RNA interference transfection
One negative control siRNA and GPR39 siRNA were designed and produced by GenePharm (Shanghai, China). MHCC-97L and Hep3B cells (2 × 10 5 per well) were transfected with 100 nmol/L siRNA.
F I G U R E 1 miR-1914 is reduced in Hepatocellular carcinoma (HCC).
Comparing the aberrant expression level of miR-1914 among (A) HCC specimens versus tumour-adjacent tissues, and (B) HCC cell lines versus LO2 cells; HCC tissues arising from different histological grade (C) and tumour size (D). *P < .05, **P < .01
| Cell proliferation, cell cycle and apoptosis detection
The procedures for EdU, colony formation, cell cycle and apoptosis analyses were performed as reported previously. 7
| Luciferase reporter assay
The 3′-UTR binding sequence of GPR39 and the associated mutated sequences were generated and inserted into the pmiR-GLO dual-luciferase miRNA target expression vector (Promega, Madison, 
| In vivo experiments
| Statistical analysis
To avoid systemic errors, each experiment was repeated more than three times. The results are displayed as the mean ± standard deviation. Student's t test or one-way ANOVA (one-way analysis of variance) followed by LSD post hoc test was conducted to compare the differences between two groups or more than two groups, respectively, with SPSS (SPSS 18.0; SPSS Inc, Chicago, IL, USA). A P value <.05 was regarded as statistically significant.
| RE SULTS
| The expression level of miR-1914 was decreased in HCC and correlated with adverse prognostic features
To assess the expression level of miR-1914 in HCC tissues, we selected 50 pairs of tissues randomly. The expression level of miR-1914 was markedly lower in the HCC samples than in the corresponding adjacent non-tumour tissues (P < .05, Figure 1A ). Likewise, the expression of miR-1914 was obviously lower in the HCC cell lines than in the physiological liver cell line L02 (P < .05, Figure 1B ). We se- Figure 1C ) and large tumour size (≥5 cm, P < .05, Figure 1D ).
| miR-1914 inhibits cell proliferation, cell cycle and colony formation and promotes apoptosis in HCC cells
To determine the efficacy of miR-1914 in HCC, a series of functional experiments were conducted using a lentivirus system to stably overexpress miR-1914 in MHCC-97L cells and knock down miR-1914 in Hep3B cells (Figure 2A , P < .05).
The results of EdU assays revealed that the overexpression of miR-1914 remarkably suppressed the proliferation of MHCC-97L cells (P < .05, Figure 2B ). Moreover, the ectopic expression of miR-1914 significantly inhibited the number of cell colonies, as confirmed by the colony formation assay (P < .05, Figure 2C ). Figure 2D ) and apoptotic cells (P < .05, Figure 2E ). Additionally, the WB results confirmed that miR-1914 overexpression obviously regulated the expression of cyclin D1, p21, Bcl-2 and Bax (P < .05, Figure 2F ). Nevertheless, miR-1914 depletion promoted cell proliferation, colony formation and G1 phase arrest and inhibited apoptosis (P < .05, Figure 2B -E). Cell cycle-and apoptosis-related proteins showed corresponding effects (P < .05, Figure 2F ). 
| GPR39 is recognized as a direct target gene of miR-1914
Target algorithms (TargetScan, miRDB and StarBase v2.0) were utilized to uncover potential targets of miR-1914. GPR39 was the predicted target ( Figure 4A ). To verify this, we examined the mRNA and protein levels of GPR39 by qRT-PCR and WB assays and demonstrated that miR-1914 significantly inversely regulated GPR39 expression (P < .05, Figure 4B,C) . Similarly, a dual-luciferase reporter assay showed that enhanced miR-1914 expression effectively suppressed the relative luciferase activity of wild-type (wt) GPR39 but not that of mutant (mt) GPR39 (P < .05, Figure 4D ).
Moreover, in clinical samples, we discovered that the expression of GPR39 was dramatically lower in high miR-1914 expression tumours than in low miR-1914 expression tumours (P < .05, Figure 4E ,F). Additionally, we determined a dramatically negative association between miR-1914 and GPR39 mRNA by Spearman's analysis in HCC samples (P < .05, Figure 4G ). Furthermore, the expression of GPR39 in xenograft tissues was analysed, and the data indicated that GPR39 expression was higher in the miR-1914 knockdown group than in the miR-1914 overexpression group (P < .05, Figure 4H ). 
| Characterization of GPR39 status in HCC
To investigate the level of expression and the potential role of GPR39 in HCC tissues, we conducted qRT-PCR and WB assays, and the results showed that GPR39 levels were much lower in adjacent non-tumour tissues than in HCC tissues (P < .05, Figure 5A,B) .
Moreover, we established stable GPR39 overexpression or knockdown cells (P < .05, Figure 5C ) by lentiviral transduction. EdU assays showed that GPR39 overexpression significantly promoted the proliferation of Hep3B cells (P < .05, Figure 5D ). The ability of colony formation confirmed that GPR39 up-regulation significantly increased the number of cell colonies (P < .05, Figure 5E ).
Moreover, flow cytometric analysis showed that the up-regulation of GPR39 resulted in cell cycle progression (P < .05, Figure 5F ) and decreased apoptosis (P < .05, Figure 5G ). Additionally, WB confirmed that GPR39 overexpression obviously regulated the cell cycle-related proteins cyclin D1 and p21 and the apoptosis-related proteins Bcl-2 and Bax (P < .05, Figure 5H ). In contrast, GPR39 silencing impeded cell proliferation and colony formation capacity, and induced G1 phase accumulation, as well as enhanced apoptosis (P < .05, Figure 5D -G). Cell cycle-and apoptosis-related proteins showed corresponding effects (P < .05, Figure 5H ). Therefore, we illustrated that GPR39 alteration could mimic the miR-1914-induced effects in HCC cells. Abbreviations: AFP, alpha-fetoprotein; HCC, hepatocellular carcinoma; TNM, tumour-node-metastasis. *P < .05.
| Restoration of GPR39 expression partially reversed the miR-1914-induced biological effects in HCC cells
For further investigate whether GPR39 was a functional target of miR-1914, we overexpressed GPR39 in miR-1914-overexpressing MHCC-97L cells (P < .05, Figure 6A ); GPR39 restoration abolished the effects of miR-1914, leading to remarkable increases in proliferation, colony formation, G1 phase arrest and apoptosis inhibition in miR-1914-overexpressing MHCC-97L cells (P < .05, Figure 6B -F).
In addition, GPR39 knockdown in miR-1914-silenced Hep3B cells partly inhibited the effects of anti-miR-1914 on tumour cell proliferation, colony formation, cell cycle progression and apoptosis (P < .05, Figure 6A -F). Thus, the data showed that GPR39 was a functional target of miR-1914 in HCC.
| miR-1914 and GPR39 expression in HCC indicates the prognosis
To confirm the clinical use of miR-1914 and GPR39 in HCC, we investigate their correlation with clinical features. As shown in Table 1 , miR-1914 down-regulation was dramatically related to large tumour size (≥5 cm; P = .011), high histological grade and increased GPR39 levels were associated with the shortest OS and DFS (P < .05, Figure 7E ,F).
| AKT phosphorylation plays a crucial role in PI3K/AKT/mTOR signalling mediated the biological effects of miR-1914 in HCC
To explore the molecular mechanisms that mediate the efficacy of miR-1914, we examined PI3K/AKT/mTOR signalling using a WB assay. As shown in Figure 8A 
| miR-1914 is negatively modulated by lncRNA DUXAP10 in HCC cells
To better elucidate the underlying mechanism by which miR-1914 was depressed in HCC, we predicted the potential targets using Starbase v2.0 and discovered that lncRNA DUXAP10 is a molecular sponge that may regulate miR-1914. First, we used the GEO database to show that DUXAP10 was obviously higher in HCC samples than in normal liver tissues, and we confirmed that DUXAP10 was higher in HCC tissues than in neighbouring non-tumour tissues ( Figure 9A , P < .05).
Spearman correlation analysis revealed a negative correlation between DUXAP10 expression and miR-1914 levels in HCC specimens (R 2 = 0.8112, P < .05, Figure 9B ). Additionally, DUXAP10 expression was knocked down with an siRNA sequence, and DUXAP10 depletion increased the level of miR-1914 in MHCC-97L cells (P < .05, Figure 9C 
| D ISCUSS I ON
To date, accumulative evidence has validated that abnormal miRNA expression is pivotal in HCC carcinogenesis and progression. 22 Numerous studies have established the potential usefulness of miRNAs as therapeutic molecules in cancers. 23, 24 Herein, our study confirmed that the level of miR-1914 was remarkably decreased in HCC specimens and cells. In addition, miR-1914 was down-regulated in tumours with a large size and high histological stage. These findings verify that miR-1914 serves as a tumour suppressor in HCC development.
Previous studies confirmed that miRNAs serve as prognostic biomarkers and valid pharmaceutical targets for HCC. 25, 26 In the present study, we corroborate that miR-1914 impedes cell prolifer- 
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